FindTrial
Sign In

Research on precise diagnosis and treatment of autoimmune liver disease and construction of standardized diagnosis and treatment system

Research on precise diagnosis and treatment of autoimmune liver disease and construction of standardized diagnosis and treatment system

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2000036198
Enrollment
Unknown
Registered
2020-08-21
Start date
2020-10-01
Completion date
Unknown
Last updated
2020-09-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Autoimmune liver disease

Interventions

case series:Nil

Sponsors

Shanghai Jiaotong University School of Medicine, Renji Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: (1) Aged 18-70 years; (2) No gender restriction; (3) Patients with clearly diagnosed autoimmune liver disease; (4) The patient agrees to participate in this trial and has signed an informed consent.

Exclusion criteria

Exclusion criteria: (1) Poor compliance or life threatening, unable to complete the experiment; (2) Other researchers think it is not suitable for participants.

Design outcomes

Primary

MeasureTime frame
AST;ALT;?-GT;AKP;IgG;—

Countries

China

Contacts

Public ContactMa Xiong

Shanghai Jiaotong University School of Medicine, Renji Hospital

maxiongmd@162.com+86 15500984550

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026